Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Jun, 5 2026
Jul, 7 2026
Oct, 17 2025
Mar, 14 2025
Jun, 1 2025